The Wall Street Journal: Pfizer to cease vaccine sales business in China

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 2 April, 2015 by The TZ Newswire Staff

The Wall Street Journal: Pfizer to cease vaccine sales business in China

Pfizer is ceasing vaccine sales operations in China after the Chinese government fails to renew an import license for one of its products, a move that the company says will cause a shortage of the treatment in China.
read more

See also
- Next Article The Wall Street Journal: Jury hits Chrysler with $150 million penalty in boy’s death
- Previous Article The Wall Street Journal: China protests Google security certificate decision
Editorial Calender

April 2015

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30

« Mar May »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 2 April, 2015 by The TZ Newswire Staff

The Wall Street Journal: Pfizer to cease vaccine sales business in China

See also

Editorial Calender

Recent Tags